Consistent with increases in phosphorylated eIF2α, protein and activity levels of BACE1, a key enzyme responsible for initiating the production of β-amyloid (Aβ) peptides, are highly elevated in AD brains [9]–[11]. Here, EIF2A is linked to Alzheimer disease.